In the present study, we examined the therapeutic effects of olmesartan, an AT1R-specific blocker, in genetically obese and diabetic KKAy mice, a model of human metabolic disorders with diabetes without any dietary loading [8], and focused our analysis on adipose tissue. This evidence concerns the gene AGTR1 and metabolic disease.